p53 alteration and human papilloma virus infection in paranasal sinus cancer

Cancer

Volumn 79, Issue 7, 1997, Pages 1320-1328

  Caruana, Salvatore M ^a,d   Zwiebel, Neil ^c   Cocker, Rubina ^b   McCormick, Steven A ^a   Eberle, Robert C ^b   Lazarus, Philip ^c,e  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b ST VINCENT S HOSPITAL   (United States)

^c AMERICAN HEALTH FOUNDATION   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

carcinoma progression; human papilloma virus; inverted papilloma; p53 tumor suppressor gene; paranasal sinus

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; DNA SEQUENCE; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; INVERTED PAPILLOMA; MALE; MUTATION; PARANASAL SINUS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; VIRUS INFECTION; WART VIRUS;

DNA MUTATIONAL ANALYSIS; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MAXILLARY SINUS NEOPLASMS; MUTATION; PAPILLOMA, INVERTED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS;

EID: 0030903418     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970401)79:7<1320::AID-CNCR8>3.0.CO;2-K     Document Type: Article

References (43)

1. Lampertico P, Russel WO, MacComb WS. Squamous papilloma of the upper respiratory epithelium. Arch Pathol Lab Med 1963;7:293-302.
2. Skolnick EM, Loewry A, Friedman JE. Inverted papilloma of the nasal cavity. Arch Otolaryngol Head Neck Surg 1966;84:64-7.
3. Ward N. Mirror of the practice of medicine and surgery in the hospitals of London: London Hospital. Lancet 1854;2:480-2.
4. Ringertz N. Pathology of malignant tumors arising in the nasal and paranasal cavities and maxilla. Acta Otolaryngol (Stockh) 1938;27(Suppl):31-42.
5. Lawson W, Ho BT, Shaari CM, Biller HF. Inverted papilloma: a report of 112 cases. Laryngoscope 1995;105:282-8.
6. Lasser A, Rothfeld PR, Shapiro RS. Epithelial papilloma and squamous cell carcinoma of the nasal cavity and paranasal sinuses: a clinicopathological study. Cancer 1976;38:2503-10.
7. Furata Y, Shinohara T, Sano K, Nagashima K, Inoue K, Tanaka K, et al. Molecular pathologic study of human papillomavirus infection in inverted papilloma and squamous cell carcinoma of the nasal cavities and paranasal sinuses. Laryngoscope 1991;101:79-85.
8. Tsuzuki H, Saito H, Imamura Y, Noriki S, Fukuda M. Early progression stage of malignancy as revealed by immunohistochemical demonstration of DNA instability. II: otorhinolaryngeal border-line neoplastic lesions. Eur J Histochem 1994;38:291-302.
9. Fukuda K, Shibata A. Exposure-response relationships between woodworking, smoking or passive smoking, and squamous cell neoplasms of the maxillary sinus. Cancer Causes Control 1990;1:165-8.
10. Chovil A, Sutherland RB, Halliday M. Respiratory cancer in a cohort of nickel sinter plant workers. Br J Ind Med 1981;38:327-33.
11. Acheson ED, Cowdell RH, Rang EH. Nasal cancer in England and Wales: an occupational survey. Br J Ind Med 1981;38:218-24.
12. Andersen C, Andersen I, Solgaard I. Nasal cancers, symptoms and upper airway function in woodworkers. Br J Ind Med 1977;34:201-7.
13. Brinton LA, Stone BJ, Blot WJ, Fraumeni JF. Nasal cancer in U.S. furniture industry counties. Lancet 1976;2:628.
14. Clifford P. Malignant disease of the nose and nasal sinuses in East Africa. Br J Surg 1960;48:15.
15. Weber RS, Shillitoe EJ, Robbins KT, Luna MA, Batsakis JG, Donovan DT, et al. Prevalance of human papillomavirus in inverted papilloma. Arch Otolaryngol Head Neck Surg 1988;114:23-6.
16. Syrjanen S, Happonen RP, Virolainen E, Siivonen L, Syrjanen K. Detection of human papilloma virus (HPV) structural antigens and DNA types in inverted papillomas and squamous cell carcinomas of the nasal cavities and paranasal sinuses. Acta Otolaryngol (Stockh) 1987;104:334-41.
17. Buchwald C, Franzmann M, Jacobsen GK, Lindeberg H. Human papillomavirus in sinonasal papillomas: a study of 78 cases using in situ hybridization and polymerase chain reaction. Laryngoscope 1995;105:66-71.
18. Kashima HK, Kessis T, Hruban RH, Wu TC, Zinreich SJ, Shah KV. Human papillomavirus in sinonasal papillomas and squamous cell carcinoma. Laryngoscope 1992;102:973-6.
19. McLachlin CM, Kandel RA, Colgan TJ, Swanson DB, Witterick IJ, Ngan BY. Prevalence of human papilloma virus in sinonasal papillomas: a study using polymerase chain reaction and in situ hybridization. Mod Pathol 1992;5:406-9.
20. Furuta Y, Takasu T, Asai T, Shinohara T, Sawa H, Nagashima K, et al. Detection of human papillomavirus DNA in carcinomas of the nasal cavities and paranasal sinuses by polymerase chain reaction. Cancer 1992;69:353-7.
21. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54:4855-78.
22. Rodrigues NR, Rowan A, Smith MEF, Kerr IB, Bodmer WF, Cannon JV, et al. p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 1990;87:7555-9.
23. Boyle JO, Hakim J, Koch W, Van der Riet P, Hruban RH, Roa RA, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993; 53:4477-80.
24. Lazarus P, Garewal HS, Sciubba J, Zwiebel N, Calcagnotto A, Fair A, et al. A low incidence of p53 mutations in premalignant lesions of the oral cavity from non-tobacco users. Int J Cancer 1995;60:458-63.
25. Sakai, E. The p53 tumor suppressor gene and ras oncogene mutations in oral squamous cell carcinoma. Int J Cancer 1992;52:867-72.
26. Somers KD, Merrick MA, Lopez ME, Incognito LS, Schechter GL, Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res 1992;52:5997-6000.
27. Brennan JA, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby YJ, et al. Association between cigarette smoking and mutation of the p53 gene in squamous cell carcinoma of the head and neck. N Engl J Med 1995;332:712-7.
28. Lazarus P, Stern J, Zwiebel N, Fair A, Richie JP Jr., Schantz S. Relationship between p53 mutation incidence in oral cavity squamous cell carcinomas and patient tobacco use history. Carcinogenesis 1996;17:733-9.
29. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990;63:1129-36.
30. Hubbert NL, Sedman SA, Schiller JT. Human papillomavirus tvpe 16 E6 increases the degradation rate of p53 in human keratinocytes. J Virol 1992;66:6237-41.
31. Soussi T, Legros Y, Lubin R, Ory K, Schlichtholz B. Multifactorial analysis of p53 alterations in human cancer: a review. Int J Cancer 1994;57:1-9.
32. Ting Y, Manos MM. Detection and typing of genital human papilloma viruses. In: PCR protocols. Innis MA, Gelfand DH, Sninsky JJ, White TJ. editors. San Diego: Academic Press, 1990:356-67.
33. Kurz J, Mitra K, Adam R, Miao X, Mackay JS, Isa NN, et al. PCR detection and typing of genital papilloma virus in a New Brunswick population. Int J Cancer 1993;55:604-8.
34. Lazarus P, Caruana S. Screening and typing of human papilloma virus using differential size PCR amplification. Anal Biochem 1996;243:198-201.
35. Gonzalez-Zuluetta M, Shibata A, Ohneseit PF, Spruck CH, Busch C, Shamaa M, et al. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder. J Natl Cancer Inst 1995;87:1383-93.
36. Cotton RGH. Current methods of mutation detection. Mutat Res 1993;285:125-44.
37. Grompe E. The rapid detection of unknown mutations in nucleic acids. Nat Genet 1993;5:111-7.
38. Sarker G, Yoon H-S, Sommer SS. Screening for mutations by RNA single-strand conformational polymorphism (rSSCP): comparison with DNA-SSCP. Nucleic Acids Res 1992;20:871-8.
39. Crook T, Tidy JA, Vousden KH. Degradation of p53 can be targeted by HPV sequences distinct from those required for p53 binding and trans-activation. Cell 1991;67:547-56.
40. Crook T, Vousden KH. Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens. EMBO J 1992;11:3935-40.
41. Fuirihata M, Ohtusuki Y, Ogoshi S, Takahashi A, Tamiya T, Ogata T. Prognostic expression of human papilloma virus genomes (types 16, -18) and abherrent expression of protein in human esophageal cancer. Int J Cancer 1993;54:226-30.
42. Hyams VJ. Papillomas of the nasal cavity and paranasal sinus. A clinicopathological study of 315 cases. Ann Otol Rhinol Laryngol 1971;80:192-206.
43. Weissler MC, Montgomery WW, Turner PA, Montgomery SK, Joseph MP. Inverted papilloma. Ann Otol Rhinol Laryngol 1989;95:1117-24.